Dr. Felicita Livia Saldanha, Dr. P. S. Balakrishna Achar


With the advent of Ambulatory surgery, the search for an ideal anaesthetic for outpatient spinal anaesthesia is ongoing.(1) An ideal anaesthetic is one that provides rapid onset of action, adequate potency, predictable duration with decreased side effects.(2) Among the various local anaesthetics available, Chloroprocaine – an amino ester – has been the forerunner in satisfying these criteria. It was first introduced in the year 1952 by Foldes and McNall and was found to be superior in efficacy and safety as compared to Procaine and Lidocaine.(3) However, due to reports of neurological deficits following intrathecal administration of chloroprocaine, in the early 1980s, its use drastically decreased and low dose Bupivacaine was preferred.(4) Extensive investigation revealed that a combination of low pH and sodium bisulfite, an antioxidant, could be the cause of neurotoxicity. Hence, an anti-oxidant and preservative free 2-choloroprocaine was developed  and is now one of the preferred drugs for short duration spinal anaesthesia.(5)


Ambulatory surgery, anaesthetic, Chloroprocaine

Full Text:



Goldblum E, Atchabahian A. The use of 2-chloroprocaine for spinal anaesthesia. Acta Anaesthesiol Scand. 2013;57(5):545–52.

Ghisi D, Bonarelli S. Ambulatory surgery with choloroprocaine spinal anesthesia. Ambul Anesth. 2015;2:111–20.

Hejtmanek MR, Pollock JE. Chloroprocaine for spinal anesthesia: A retrospective analysis. Acta Anaesthesiol Scand. 2011;55(3):267–72.

Lacasse MA, Roy JD, Forget J, Vandenbroucke F, Seal RF, Beaulieu D, et al. Comparison of bupivacaine and 2-chloroprocaine for spinal anesthesia for outpatient surgery: A double-blind randomized trial. Can J Anesth. 2011;58(4):384–91.

Casati A, Danelli G, Berti M, Fioro A, Fanelli A, Benassi C, et al. Intrathecal 2-chloroprocaine for lower limb outpatient surgery: A prospective, randomized, double-blind, clinical evaluation. Anesth Analg. 2006;103(1):234–8.

Vath JS, Kopacz DJ. Spinal 2-Chloroprocaine: The Effect of Added Fentanyl. Anesth Analg. 2004;(8):89–94.

Ben-David B, Miller G, Gavriel R, Gurevitch A. Low-dose bupivacaine-fentanyl spinal anaesthesia for caesarean delivery. Reg Anesth Pain Med. 2000;25(3):235-9.

Swain A, Nag DS, Sahu S, Samaddar DP, Swain A, Nag DS, et al. future trends. 2017;5(8):307–24.

Liu S, Chiu AA, Carpenter RL, et al. Fentanyl prolongs lidocaine spinal anesthesia without prolonging recovery. Anesth Analg 1995;80:730–4.

Yesuf KA, Gebremedhn EG, Melkie TB. Analgesic effect on intrathecal fentanyl as an adjuvant to spinal anaesthesia in comparison with spinal anaesthesia with Bupivacaine only for mothers delivered by emergency caesarean section. J Anesth Crit Care Open Access 2017;7(5): 00278.

Bhaskara B, Prabhakar SA, Rangadhamaiah R. Intrathecal 1% 2-Chloroprocaine with fentanyl in comparison with ropivacaine (0.5%) with fentanyl in day care perianal surgery: Prospective randomized comparative study. Anesth Essays Res 2019;13:471-5.

Yoos JR, Kopacz DJ. Spinal 2-Chloroprocaine for Surgery: An Initial 10-Month Experience. Anesth Analg 2004;99:553–8.

Saporitoa A, Ceppib M, Perrenc A, La Reginad D, Cafarottid S, Borgeate A, et al. Does spinal chloroprocaine pharmacokinetic profile actually translate into a clinical advantage in terms of clinical outcomes when compared to low-dose spinal bupivacaine? A systematic review and meta-analysis. Journal of Clinical Anesthesia 2019;52:99–104.

Seetharam KR, Bhat G. Effects of isobaric ropivacaine with or without fentanyl in subarachnoid blockade: A prospective double-blind, randomized study. Anesth Essays Res 2015;9:173-7.

Kaur M. Adjuvants to local anaesthetics: A combination wisdom. Anesth Essays Res. 2010;4(2):122-23.

Wahal C, Kumar A, Pyati S. Advances in regional anaesthesia: A review of current practice, newer techniques and outcomes. Indian J Anaesth 2018;62:94-102.

Palamara C, Abid N, Badet L, Boselli E, Dominique I. Evaluation of spinal anesthesia in urological outpatient surgery, comparison between two local anaesthetics (Chloroprocaine/Bupivacaine). Prog Urol. 2019;29(8-9):402-7.


  • There are currently no refbacks.